. "Committee Biographies." Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices. Washington, DC: The National Academies Press, 1999.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices
Sara Rosenbaum, JD, is director of the Center and professor in the Department of Health Services Management and Policy in the School of Public Health and Health Services at The George Washington University. Ms. Rosenbaum also holds appointments in the Schools of Law and Medicine and Health Sciences. Ms. Rosenbaum has worked extensively in the areas of health law for the poor, health care financing and managed care, and maternal and child health. During 1993 and 1994 she worked with the White House Domestic Policy Council and the United States Department of Health and Human Services, where she directed the legislative drafting of the Health Security Act for the President. She has served on policy advisory boards for the United States Congress Office of Technology Assessment, the United States Public Health Service, and the Health Care Financing Administration.
Cathy Schoen, MA joined The Commonwealth Fund in September 1995 as director of research and evaluation. Prior to joining the Fund, she was director of special projects at the University of Massachusetts Labor Relations and Research Center. She also serves as program director of the Fund's Health Care Coverage and Quality Program, a policy and research grant program established to help inform national and state health insurance and delivery system policy decisions.
Jane Sisk, PhD, is Professor of Public Health and Director of the Master's Program in Effectiveness and Outcomes Research at Columbia University. Her current research is focusing on the cost-effectiveness of health care interventions, including pneumococcal vaccination for elderly people, implementation of evidence-based guidelines, and evaluation of Medicaid managed care. Before coming to Columbia in 1990, Dr. Sisk directed health policy projects at the Congressional Office of Technology Assessment, where she was a Senior Associate and Project Director in the Health Program.
Rosemary Chalk, BA (Study Director) has been a member of the professional staff of the Institute of Medicine and the National Research Council since 1987. She has directed studies and edited reports on family violence, child abuse and neglect, child welfare, youth development, research ethics, and education finance.
Jane Durch, MA, (Project Officer) joined the staff of the Institute of Medicine in 1990. She has participated in studies on children's health, immunization, vaccine development, monitoring the health of Gulf War veterans, and performance measurement in public health programs and in community health improvement activities.